Loading...
Immunotherapies for Infectious Diseases Congress 2018

December 10 - 11 LYON - Matmut Stadium

News Twitter

Programme

schedule & speakers

Your company develops immunotherapies for infectious diseases and you want to present your scientific work at the I4ID 2018 congress? Check-out our sponsors & partners page to discover our sponsored presentation opportunities.

Day 1

Monday 10 December 2018

8h30

Registration & welcome coffee

9h15

Welcome address

9h30

Keynote Lecture

10h30

Session I – Targeting the Immune system to fight Bacterial Infections

• Immunomodulators
• Fighting Tuberculosis
• Treatment against sepsis
• Fighting fungal infections
• Immunotherapy combination treatments: using immune checkpoint inhibitors

11h00

Coffee break & Poster Session at Exhibition Hall | Partnering (B2B meetings)

11h30

Session I – Targeting the Immune system to fight Bacterial Infections

12h30

Lunch break & Poster Session at Exhibition Hall | Partnering (B2B meetings)

14h30

Session II – Targeting the Immune system to fight Viral Infections

• Immunomodulators
• HIV
• Hepatitis
• chronical infectious diseases
• Influenza
• Immunotherapy combination treatments: using immune checkpoint inhibitors

15h30

Coffee break & Poster Session at Exhibition Hall | Partnering (B2B meetings)

16h00

Pitch Session – Innovation on HDT approaches to treat Infectious Diseases

Selection of the best 10 abstracts to give a 10min talk.

19h00

End of day one

20h00

Gala Evening

Day 2

Tuesday 11 December 2018

8h00

Welcome coffee

8h30

Keynote Lecture

9h00

Session III – Accelerate the Validation & Development of Host-direct therapies

• Characterization
• Bioanalysis
• Bioproduction

10h30

Coffee break & Poster Session at Exhibition Hall | Partnering (B2B meetings)

11h00

Session IV – Bringing into clinic Host-directed therapies: safety and efficiency

• Companion diagnostics
• Biomarkers
• Off-targets prediction
• Better manage efficiency/safety
• Defining population to treatment target

12h30

Lunch break & Poster Session at Exhibition Hall | Partnering (B2B meetings)

14h30

Session V – Developing Next-Generation of host-directed therapies

• Screening & Discovery of cellular targets for host directed therapies
• Microbiome
• Identification of cellular targets for host directed therapies
• Methods to identify new host directed therapies

17h00

Session VI - Prize of the Best Pitch and Best Poster

17h15

Closing remarks

17h30

End of Congress